Moderna (Coinbase Tokenized Stock) - Logo
Moderna (Coinbase Tokenized Stock)MRNAc

Moderna (Coinbase Tokenized Stock)MRNAc

IssuerCoinbase
Launch dateSep 28, 2026

Moderna (Coinbase Tokenized Stock) (MRNAc) is a tokenized share of MRNA issued by Coinbase through Coinbase Onchain SPV Ltd and distributed through Onchain Marketplace Ltd with Alpaca Securities LLC as broker. The underlying security is listed in the health care sector in North America. Each token represents one underlying share, entitles holders to dividends, which are reinvested into the token, and carries voting rights. The underlying shares are held by Alpaca in accounts segregated from the issuer's own funds, with Onchain Marketplace Ltd as transfer agent and Deloitte & Touche (M.E.) LLP as auditor. Residents of the United States cannot mint or redeem with Coinbase. Coinbase Onchain SPV Ltd is offered under an SEC Regulation S exemption, is regulated in Abu Dhabi's ADGM, and is supervised by the Abu Dhabi Global Market Financial Services Regulatory Authority. Holder terms are governed by the law of the United Arab Emirates. MRNAc has been issued on Base as a B20 token since September 2026.

All metrics